Juvenile-onset dentatorubral-pallidoluysian atrophy with recurrent deterioration and recovery of cognitive and motor function: A case report

Background Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in the ATN1 gene. Juvenile-onset DRPLA typically presents with ataxia, myoclonus, epilepsy, and progressive deterioration. However, large-amplitude fluctuations in neurological status have rarely been reported. Case presentation We report a 10-year-old Japanese boy with juvenile-onset DRPLA who exhibited an atypical clinical course characterized by recurrent episodes of marked neurological deterioration followed by improvement. From age 4, he developed periodic brief leg stiffening. From age 5, he experienced recurrent episodes lasting several weeks that included drooling, brief hand drops, and brief leg stiffening. Around age 6, prominent neurological fluctuations recurred approximately every 3 months. During these episodes, myoclonic seizures increased, responsiveness and verbal output progressively decreased, and he eventually became unable to maintain a sitting position without support and lost verbal output. These periods generally lasted several weeks, followed by gradual improvement with regained speech and the ability to walk with assistance, apparently independent of major antiseizure medication (ASM) modifications. His neurological condition subsequently worsened, and by age 8 he became continuously bedridden and exhibited high-amplitude generalized spike-and-wave discharges on electroencephalography (EEG). After discontinuation of topiramate and perampanel, both neurological function and EEG findings markedly improved. He regained independent ambulation and speech, with no recurrence of epileptic seizures for 2 years. Discussion/Conclusion This case illustrates a clinical course characterized by large-amplitude, recurrent fluctuations in neurological status followed by ASM-related deterioration. Careful assessment is needed to avoid misattributing potentially reversible ASM-related adverse effects to irreversible disease progression.

Authors

Institutions

Publication Details

Journal
Brain and Development Case Reports
Published
2026-11-21
DOI
https://doi.org/10.1016/j.bdcasr.2026.100170
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Juvenile-onset dentatorubral-pallidoluysian atrophy with recurrent deterioration and recovery of cognitive and motor function: A case report

Tokito Yamaguchi, Kyoko Takano, Katsumi Imai, Mitsuhiro Miyashita et al.
Brain and Development Case Reports
Genetic Neurodegenerative Diseases
article

Juvenile-onset dentatorubral-pallidoluysian atrophy with recurrent deterioration and recovery of cognitive and motor function: A case report

Tokito Yamaguchi, Kyoko Takano, Katsumi Imai, Mitsuhiro Miyashita, Ryojun Takeda, Ryosuke Suzui, Mitsuo Motobayashi, Shino Shimada, Yu Tsuyusaki, Yukitoshi Takahashi, Satoshi Mizutani, Hideyuki Ohtani, Manami Yabe
article en

Abstract

Background Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in the ATN1 gene. Juvenile-onset DRPLA typically presents with ataxia, myoclonus, epilepsy, and progressive deterioration. However, large-amplitude fluctuations in neurological status have rarely been reported. Case presentation We report a 10-year-old Japanese boy with juvenile-onset DRPLA who exhibited an atypical clinical course characterized by recurrent episodes of marked neurological deterioration followed by improvement. From age 4, he developed periodic brief leg stiffening. From age 5, he experienced recurrent episodes lasting several weeks that included drooling, brief hand drops, and brief leg stiffening. Around age 6, prominent neurological fluctuations recurred approximately every 3 months. During these episodes, myoclonic seizures increased, responsiveness and verbal output progressively decreased, and he eventually became unable to maintain a sitting position without support and lost verbal output. These periods generally lasted several weeks, followed by gradual improvement with regained speech and the ability to walk with assistance, apparently independent of major antiseizure medication (ASM) modifications. His neurological condition subsequently worsened, and by age 8 he became continuously bedridden and exhibited high-amplitude generalized spike-and-wave discharges on electroencephalography (EEG). After discontinuation of topiramate and perampanel, both neurological function and EEG findings markedly improved. He regained independent ambulation and speech, with no recurrence of epileptic seizures for 2 years. Discussion/Conclusion This case illustrates a clinical course characterized by large-amplitude, recurrent fluctuations in neurological status followed by ASM-related deterioration. Careful assessment is needed to avoid misattributing potentially reversible ASM-related adverse effects to irreversible disease progression.

Brain and Development Case ReportsVol. 4(4)
National Epilepsy Center (JP), National Center for Global Health and Medicine (JP), Shinshu University Hospital (JP), Nagano Children's Hospital (JP), Kashiwa Municipal Hospital (JP)
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon